Referințe științifice

  1. 1. ACOG Committee on Practice Bulletins—Gynecology. ACOG practice bulletin No. 72: Clinical management guidelines for obstetrician-gynecologists. Vaginitis. Obstet Gynecol. 2006;107(5):1195-206.
  2. 2. Amabebe E, Anumba DOC. The vaginal microenvironment: The physiologic role of Lactobacilli. Front Med (Lausanne). 2018;5:181. doi:10.3389/fmed.2018.00181.
  3. 3. Brett D. A review of collagen and collagen-based wound dressings. Wounds. 2008;20(12):347-56. PMID:25941895.
  4. 4. Brusselaers N, Shrestha S, van de Wijgert J, Verstraelen H. Vaginal dysbiosis and the risk of human papillomavirus and cervical cancer: A systematic review and meta-analysis. Am J Obstet Gynecol. 2019;221(1):9-18.e8. doi:10.1016/j.ajog.2018.12.011.
  5. 5. Carlson K, Nguyen H. Genitourinary syndrome of menopause. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026. Updated 2024 Oct 5. Available from: https://www.ncbi.nlm.nih.gov/books/NBK559297/
  6. 6. Chattopadhyay S, Raines RT. Collagen-based biomaterials for wound healing. Biopolymers. 2014;101(8):821-33. doi:10.1002/bip.22486.
  7. 7. Couto EV, Ballin CR, Sampaio CP, Maeda CA, Ballin CH, Dassi CS, et al. Experimental study on the effects of bismuth subgallate on the inflammatory process and angiogenesis of the oral mucosa. Braz J Otorhinolaryngol. 2016;82(1):17-25. doi:10.1016/j.bjorl.2014.12.009.
  8. 8. Donders GGG, Vereecken A, Bosmans E, Dekeersmaecker A, Salembier G, Spitz B. Definition of a type of abnormal vaginal flora that is distinct from bacterial vaginosis: Aerobic vaginitis. BJOG. 2002;109(1):34-43.
  9. 9. Hildebrand JP, Carlson K, Kansagor AT. Vaginitis. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026. Updated 2025 Jan 19. Available from: https://www.ncbi.nlm.nih.gov/books/NBK470302/
  10. 10. Kaambo E, Africa C, Chambuso R, Passmore JAS. Vaginal microbiomes associated with aerobic vaginitis and bacterial vaginosis. Front Public Health. 2018;6:78. doi:10.3389/fpubh.2018.00078.
  11. 11. Lin YP, Chen WC, Cheng CM, Shen CJ. Vaginal pH value for clinical diagnosis and treatment of common vaginitis. Diagnostics (Basel). 2021;11(11):1996. doi:10.3390/diagnostics11111996.
  12. 12. Paladine HL, Desai UA. Vaginitis: Diagnosis and treatment. Am Fam Physician. 2018;97(5):321-9.
  13. 13. Petre I, Sirbu DT, Petrita R, Calancea FL, Toma AD, Peta E, et al. Real-world performance and safety of Cerviron® medical device in the treatment of various types of vaginitis. Biomed J Sci Tech Res. 2022;47(5):38785-38797.
  14. 14. Petre I, Sirbu DT, Petrita R, Toma AD, Peta E, Dimcevici-Poesina F. Real world study of Cerviron® vaginal ovules in the treatment of cervical lesions of various etiologies. Biomed Rep. 2023;19(2):54. doi:10.3892/br.2023.1647.
  15. 15. Petre I, Toader DO, Petrita R, Pinta AR, Alexa AA, Bita RG. Clinical performance and safety of Cerviron® vaginal ovules in the management of symptomatic cervical lesions: A national, multicentric study. Curr Ther Res Clin Exp. 2024;101:100762. doi:10.1016/j.curtheres.2024.100762.
  16. 16. Savini V, Marrollo R, D’Antonio M, D’Amario C, Fazii P, D’Antonio D. Streptococcus agalactiae vaginitis: Nonhemolytic variant on the Liofilchem® Chromatic StreptoB. Int J Clin Exp Pathol. 2013;6(8):1693-5.
  17. 17. Tramontina VA, Machado MA, Nogueira Filho GR, Kim SH, Vizzioli MR, Toledo S. Effect of bismuth subgallate (local hemostatic agent) on wound healing in rats: Histological and histometric findings. Braz Dent J. 2002;13(1):11-6. PMID:11870955.
  18. 18. Yandell P, Korzendorfer H, Hettrick H, Gokoo C. The use of collagen dressings in long-term care: A retrospective case series. Wounds. 2011;23(8):243-51. PMID:25879235.
  19. 1. ACOG Committee on Practice Bulletins—Gynecology. ACOG practice bulletin No. 72: Clinical management guidelines for obstetrician-gynecologists. Vaginitis. Obstet Gynecol. 2006;107(5):1195-206.
    2. Amabebe E, Anumba DOC. The vaginal microenvironment: The physiologic role of Lactobacilli. Front Med (Lausanne). 2018;5:181. doi:10.3389/fmed.2018.00181.
    3. Brett D. A review of collagen and collagen-based wound dressings. Wounds. 2008;20(12):347-56. PMID:25941895.
    4. Brusselaers N, Shrestha S, van de Wijgert J, Verstraelen H. Vaginal dysbiosis and the risk of human papillomavirus and cervical cancer: A systematic review and meta-analysis. Am J Obstet Gynecol. 2019;221(1):9-18.e8. doi:10.1016/j.ajog.2018.12.011.
    5. Carlson K, Nguyen H. Genitourinary syndrome of menopause. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026. Updated 2024 Oct 5. Available from: https://www.ncbi.nlm.nih.gov/books/NBK559297/
    6. Chattopadhyay S, Raines RT. Collagen-based biomaterials for wound healing. Biopolymers. 2014;101(8):821-33. doi:10.1002/bip.22486.
    7. Couto EV, Ballin CR, Sampaio CP, Maeda CA, Ballin CH, Dassi CS, et al. Experimental study on the effects of bismuth subgallate on the inflammatory process and angiogenesis of the oral mucosa. Braz J Otorhinolaryngol. 2016;82(1):17-25. doi:10.1016/j.bjorl.2014.12.009.
    8. Donders GGG, Vereecken A, Bosmans E, Dekeersmaecker A, Salembier G, Spitz B. Definition of a type of abnormal vaginal flora that is distinct from bacterial vaginosis: Aerobic vaginitis. BJOG. 2002;109(1):34-43.
    9. Hildebrand JP, Carlson K, Kansagor AT. Vaginitis. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026. Updated 2025 Jan 19. Available from: https://www.ncbi.nlm.nih.gov/books/NBK470302/
    10. Kaambo E, Africa C, Chambuso R, Passmore JAS. Vaginal microbiomes associated with aerobic vaginitis and bacterial vaginosis. Front Public Health. 2018;6:78. doi:10.3389/fpubh.2018.00078.
    11. Lin YP, Chen WC, Cheng CM, Shen CJ. Vaginal pH value for clinical diagnosis and treatment of common vaginitis. Diagnostics (Basel). 2021;11(11):1996. doi:10.3390/diagnostics11111996.
    12. Paladine HL, Desai UA. Vaginitis: Diagnosis and treatment. Am Fam Physician. 2018;97(5):321-9.
    13. Petre I, Sirbu DT, Petrita R, Calancea FL, Toma AD, Peta E, et al. Real-world performance and safety of Cerviron® medical device in the treatment of various types of vaginitis. Biomed J Sci Tech Res. 2022;47(5):38785-38797.
    14. Petre I, Sirbu DT, Petrita R, Toma AD, Peta E, Dimcevici-Poesina F. Real world study of Cerviron® vaginal ovules in the treatment of cervical lesions of various etiologies. Biomed Rep. 2023;19(2):54. doi:10.3892/br.2023.1647.
    15. Petre I, Toader DO, Petrita R, Pinta AR, Alexa AA, Bita RG. Clinical performance and safety of Cerviron® vaginal ovules in the management of symptomatic cervical lesions: A national, multicentric study. Curr Ther Res Clin Exp. 2024;101:100762. doi:10.1016/j.curtheres.2024.100762.
    16. Savini V, Marrollo R, D’Antonio M, D’Amario C, Fazii P, D’Antonio D. Streptococcus agalactiae vaginitis: Nonhemolytic variant on the Liofilchem® Chromatic StreptoB. Int J Clin Exp Pathol. 2013;6(8):1693-5.
    17. Tramontina VA, Machado MA, Nogueira Filho GR, Kim SH, Vizzioli MR, Toledo S. Effect of bismuth subgallate (local hemostatic agent) on wound healing in rats: Histological and histometric findings. Braz Dent J. 2002;13(1):11-6. PMID:11870955.
    18. Yandell P, Korzendorfer H, Hettrick H, Gokoo C. The use of collagen dressings in long-term care: A retrospective case series. Wounds. 2011;23(8):243-51. PMID:25879235.